FDA
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces 2025 Annual Results
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals finds Babesia in 24% of chronic fatigue patients
-
-
-
-
-
-
-
H.C. Wainwright Assumes 60 Degrees Pharmaceuticals Inc (SXTP) at Buy
-
-
-
-
-
-
-
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


